Bcl6 and transcription factors that program TFH differentiation and function

Bcl6 和转录因子编程 TFH 分化和功能

基本信息

  • 批准号:
    10224892
  • 负责人:
  • 金额:
    $ 30.24万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-08-01 至 2022-04-01
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY / ABSTRACT Project 1 (Crotty) Helper T cell differentiation and function are important processes for many diseases. Vaccines are one of the most cost effective medical treatments in modern civilization. The vast majority of current human vaccines function by eliciting protective antibody responses. T cell help to B cells is a fundamental aspect of adaptive immunity to many pathogens. Follicular helper CD4 T cells (Tfh) are the specialized providers of help to B cells. Therefore, there is substantial potential for an improved understanding of Tfh cells to facilitate better anti- pathogen immune responses and vaccine-elicited humoral immunity. Work by our laboratory and others established that TFH cells depend on expression of the transcription factor Bcl6 and other transcription factors. Despite these advances, the pathways that control TFH differentiation and define TFH functions remain poorly understood. In Project 1, we will characterize, stratify, and interconnect TFs, chromatin regulators, and helper molecules that control TFH differentiation and function, leveraging our current tools and our team’s knowledge of related pathways in CD8 T cells (Projects 2 & 3). Aim 1. To understand the mechanisms of action of Bcl6 in TFH cell differentiation and function. Bcl6 is the lineage defining transcription factor of TFH cells. How Bcl6 accomplishes control of TFH differentiation and function remains unclear, because of the complexity of the biology. Based on preliminary data, our operating model is that Bcl6 controls TFH differentiation by repressor-of- repressor mechanisms. Putative mechanisms will be comprehensively tested. Aim 2. Aim 1 has identified and will identify key Bcl6-r TFs. In Aim 2 we explore the biology of these TFs and the putative mechanisms by which these TFs control TFH. Aim 3. TFH help to B cells is a multifaceted process for which much is still unknown regarding the molecules involved. This is in part because it is a complex set of functions, and in part because of previous technological limitations. It is likely that elucidating the immunobiology underlying the differentiation of Tfh cells and the process of generating protective antiviral antibody responses will reveal vaccinology principles that can be applied to future vaccine development against infectious scourges.
项目摘要/摘要 项目1(Crotty) 辅助性T细胞的分化和功能是许多疾病的重要过程。疫苗是 现代文明中最具成本效益的医疗方法。目前绝大多数的人类疫苗 通过激发保护性抗体反应发挥作用。T细胞对B细胞的帮助是适应性的一个基本方面 对许多病原体免疫。滤泡辅助性T细胞(TFH)是为B细胞提供帮助的专门化细胞。 因此,对TFH细胞的了解有很大的潜力,以促进更好的抗 病原体免疫反应和疫苗诱导的体液免疫。我们的实验室和其他机构的工作 证实TFH细胞依赖转录因子Bcl6和其他转录因子的表达。 尽管有这些进展,但控制TFH分化和确定TFH功能的途径仍然很差 明白了。在项目1中,我们将对TF、染色质调节器和助手进行表征、分层和互连 控制TFH分化和功能的分子,利用我们现有的工具和我们团队对 CD8T细胞中的相关通路(方案2和3)。目的1.了解Bcl6在TFH中的作用机制 细胞分化和功能。Bcl6是TFH细胞的家族决定转录因子。Bcl6如何 完成对TFH分化的控制,由于TFH的复杂性,其功能尚不清楚 生物学。根据初步数据,我们的操作模型是Bcl6通过抑制-Of-TFH来控制TFH的分化 抑制器机制。将对可能的机制进行全面测试。目标2.目标1已确定和 将确定关键的Bcl6-r TF。在目标2中,我们探索了这些转铁蛋白的生物学和可能的机制 这些TF控制着TFH。目的3.转铁蛋白对B细胞的帮助是一个多方面的过程,其中许多方面尚不清楚 关于涉及的分子。这在一定程度上是因为它是一组复杂的函数,还有一部分原因是 以前的技术限制。很可能,阐明肿瘤分化的免疫生物学基础 TFH细胞和产生保护性抗病毒抗体反应的过程将揭示疫苗学原理 这可以应用于未来针对传染性疾病的疫苗开发。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Shane P Crotty其他文献

Shane P Crotty的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Shane P Crotty', 18)}}的其他基金

Immune engineering of optimized sequential immunization strategies for HIV vaccines
HIV疫苗序贯免疫策略优化的免疫工程
  • 批准号:
    10588202
  • 财政年份:
    2021
  • 资助金额:
    $ 30.24万
  • 项目类别:
Immune engineering of optimized sequential immunization strategies for HIV vaccines
HIV疫苗序贯免疫策略优化的免疫工程
  • 批准号:
    10383728
  • 财政年份:
    2021
  • 资助金额:
    $ 30.24万
  • 项目类别:
T follicular helper (Tfh) CD4+ T cell, germinal center, and antibody response dysfunction in human recurrent tonsillitis
人复发性扁桃体炎中滤泡辅助性 T (Tfh) CD4 T 细胞、生发中心和抗体反应功能障碍
  • 批准号:
    10304742
  • 财政年份:
    2020
  • 资助金额:
    $ 30.24万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10591866
  • 财政年份:
    2020
  • 资助金额:
    $ 30.24万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10224889
  • 财政年份:
    2020
  • 资助金额:
    $ 30.24万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10024584
  • 财政年份:
    2020
  • 资助金额:
    $ 30.24万
  • 项目类别:
Bcl6 and transcription factors that program TFH differentiation and function
Bcl6 和转录因子编程 TFH 分化和功能
  • 批准号:
    10683269
  • 财政年份:
    2020
  • 资助金额:
    $ 30.24万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10683257
  • 财政年份:
    2020
  • 资助金额:
    $ 30.24万
  • 项目类别:
Transcription factor regulation of CD4 and CD8 T cell effector and memory differentiation and function
CD4 和 CD8 T 细胞效应及记忆分化和功能的转录因子调节
  • 批准号:
    10024583
  • 财政年份:
    2020
  • 资助金额:
    $ 30.24万
  • 项目类别:
Functional and dysfunctional human CD4 T cell and B cell responses to bacteria and viruses
功能性和功能失调的人类 CD4 T 细胞和 B 细胞对细菌和病毒的反应
  • 批准号:
    10285994
  • 财政年份:
    2020
  • 资助金额:
    $ 30.24万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 30.24万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 30.24万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 30.24万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.24万
  • 项目类别:
    Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 30.24万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 30.24万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 30.24万
  • 项目类别:
    Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
  • 批准号:
    10699504
  • 财政年份:
    2023
  • 资助金额:
    $ 30.24万
  • 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
  • 批准号:
    10491642
  • 财政年份:
    2023
  • 资助金额:
    $ 30.24万
  • 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
  • 批准号:
    10782567
  • 财政年份:
    2023
  • 资助金额:
    $ 30.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了